Glucocorticoid-Induced Leucine Zipper Is Protective in Th1-Mediated Models of Colitis-Reference-Cited by-同舟云学术

Glucocorticoid-Induced Leucine Zipper Is Protective in Th1-Mediated Models of Colitis

Published:2009-02 Issue:2 Volume:136 Page:530-541
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Cannarile Lorenza,Cuzzocrea Salvatore,Santucci Luca,Agostini Massimiliano,Mazzon Emanuela,Esposito Emanuela,Muià Carmelo,Coppo Maddalena,Di Paola Rosanna,Riccardi Carlo

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference36 articles.

1. The immunological and genetic basis of inflammatory bowel disease;Bouma;Nat Rev Immunol,2003

2. The fundamental basis of inflammatory bowel disease;Strober;J Clin Invest,2007

3. Regulation of T-cell apoptosis in inflammatory bowel disease: to die or not to die, that is the mucosal question;Neurath;Trends Immunol,2001

4. T cells orchestrate intestinal mucosal shape and integrity;MacDonald;Immunol Today,1999

5. Protection from experimental colitis by theaflavin-3,3′-digallate correlates with inhibition of IKK and NF-kappaB activation;Ukil;Br J Pharmacol,2006

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic glucocorticoid therapy for SLE;Dubois' Lupus Erythematosus and Related Syndromes;2025

2. Anti-Inflammatory Effects of Synthetic Peptides Based on Glucocorticoid-Induced Leucine Zipper (GILZ) Protein for the Treatment of Inflammatory Bowel Diseases (IBDs);Cells;2023-09-16

3. GILZ Modulates the Recruitment of Monocytes/Macrophages Endowed with a Resolving Phenotype and Favors Resolution of Escherichia coli Infection;Cells;2023-05-17

4. The novel role of glucocorticoid-induced leucine zipper as a marker of mucosal healing in inflammatory bowel diseases;Pharmacological Research;2022-08

5. GILZ regulates type I interferon release and sequesters STAT1;Journal of Autoimmunity;2022-07